Clinical Trial Search Results

625 studies were found about ( ritonavir OR Norvir )
Filter Results: All Studies Studies seeking new volunteers Studies with results

Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine

Condition: Acute HIV Infection; HIV Infections

NCT ID: NCT00855413

A Study to Assess the Pharmacokinetics (Blood Levels) of TMC114 (Darunavir) Taken With Ritonavir and/or TMC125 (Etravirine) and TMC278 (Rilpivirine) in HIV-1 Infected Pregnant Women

Condition: HIV; HIV Infections; Pregnancy

NCT ID: NCT00855335

A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents

Condition: HIV-1; HIV Infections

NCT ID: NCT00355524

A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment

Condition: Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus

NCT ID: NCT01448707

Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults

Condition: HIV; HIV Infections

NCT ID: NCT01108510

Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV; HIV Infections

NCT ID: NCT01106586

Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir

Condition: HIV Infections; AIDS Virus; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome Virus

NCT ID: NCT00458302

Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT01516970

Phase 3B Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Versus Ritonavir-Boosted Atazanavir Plus Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Women

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01705574

Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT01475838

An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT01541085

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00993148

HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00450580

GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00257621

Phase IIIb Study to Evaluate the Effectiveness and Safety of Atazanavir/Ritonavir as Single Enhanced Protease Inhibitor Therapy in Human Immunodeficiency Virus (HIV)-Infected Subjects Evidencing Virologic Suppression

Condition: Human Immunodeficiency Virus (HIV) Infections

NCT ID: NCT00337467

Maintenance Boosted Lopinavir Monotherapy Following Salvage Protease-inhibitor (PI) Based Regimen in HIV With Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) Based Regimen Failure

Condition: HIV; AIDS; Lopinavir; Treatment Failure

NCT ID: NCT01189695

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

A Study of an Investigational Regimen Combining FDA Approved HIV Drugs in HIV-Infected Subjects

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00363142

Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001083

A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Condition: HIV Infections

NCT ID: NCT00000892

A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children

Condition: HIV Infections

NCT ID: NCT00000952

Part A: Drug Interaction Study of GS-7977 and Antiretroviral Therapy(ART) Combinations in Human Immunodeficiency Virus and Hepatitis C Virus (HIV/HCV) Co-infected Patients. Part B: Phase 2, Open-Label Study to Investigate Efficacy and Safety of GS-7977 for 12 Weeks in HIV/HCV Co-infected Patients.

Condition: Hepatitis C; HIV

NCT ID: NCT01565889

Once-Daily Drug Regimen for HIV-Infected Patients

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00001968

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002451

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Condition: Antiretroviral Therapy in HIV-1 Infected Children

NCT ID: NCT01196195

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00004581

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00440947

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00051831

Safety and Effectiveness of an Anti-HIV Drug Combination in HIV-Positive Patients Who Have Failed Previous Treatment With Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002361

The Pharmacokinetics of Double Boosted Protease Inhibitors in Antiretroviral-naive HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00400738

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

Condition: Infection, Human Immunodeficiency Virus I; HIV-1 Infection

NCT ID: NCT00242879

A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002201

Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People

Condition: HIV Infections

NCT ID: NCT00028366

Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients

Condition: HIV Infection

NCT ID: NCT00420355

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Condition: HIV Infections

NCT ID: NCT00025727

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Condition: HIV Infections

NCT ID: NCT00038480

Ritonavir and Agenerase Treatment for Patients Who Have Failed Previous Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00006591

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001075

The Safety and Effectiveness of Indinavir Plus Ritonavir Plus Two NRTIs in HIV-Infected Patients Who Need Early Intervention Treatment

Condition: HIV Infections

NCT ID: NCT00005118

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Condition: Sarcoma, Kaposi; HIV Infections

NCT ID: NCT00002366

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their Babies

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000888

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

Condition: HIV; HIV-1; Human Immunodeficiency Virus

NCT ID: NCT00298350

Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications

Condition: Opioid Dependency; HIV Infections

NCT ID: NCT00877591

Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects

Condition: HIV Infections

NCT ID: NCT00654147

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Condition: HIV Infections

NCT ID: NCT00421551

Safety Study of Lopinavir/Ritonavir With Raltegravir in HIV-infected Patients

Condition: HIV Infections

NCT ID: NCT00752037

Safety and Tolerance of Indinavir Plus Ritonavir in HIV-Positive Patients Failing Therapy With Amprenavir, Nelfinavir, or Saquinavir

Condition: HIV Infections

NCT ID: NCT00001133

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Condition: HIV Infections

NCT ID: NCT00424814

Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00000906

A Study to Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002448

A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Condition: HIV Infections

NCT ID: NCT00000859

Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

Condition: HIV Infection; Mitochondrial Dysfunction

NCT ID: NCT01194856

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Antiretroviral (ARV) Naive Patients Starting Treatment With Anti-HCV Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437476

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00002223

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00038519

ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00004578

Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment

Condition: HIV Infections

NCT ID: NCT00005017

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART

Condition: HIV Infections

NCT ID: NCT00038532

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug Therapy

Condition: HIV Infections

NCT ID: NCT00004583

Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)

Condition: HIV Infections

NCT ID: NCT00665951

Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.

Condition: HIV Integrase, HIV Protease.

NCT ID: NCT01258374

Comparison of Efficacy and Safety of Infant Peri-exposure Prophylaxis With Lopinavir/Ritonavir Versus Lamivudine to Prevent HIV-1 Transmission by Breastfeeding

Condition: HIV Infections

NCT ID: NCT00640263

Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment

Condition: HIV Infections

NCT ID: NCT00544128

A Study to Compare Three Doses of T-20 When Given in Combination With Abacavir, Amprenavir, Ritonavir, and Efavirenz to HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00002239

TMC114-TiDP29-C228 - A Safety Study to Evaluate the Antiviral Activity of Darunavir (DRV) in Combination With Ritonavir (Rtv) in HIV 1 Infected Children From 3 Years to Below 6 Years of Age

Condition: HIV Infections

NCT ID: NCT00919854

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00004580

A Study to Compare Two Anti-HIV Drug Combinations

Condition: HIV Infections

NCT ID: NCT00002447

Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants

Condition: Human Immunodeficiency Virus Type 1 (HIV-1); HIV Infections

NCT ID: NCT00833482

Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users

Condition: HIV Infections; Hepatitis C

NCT ID: NCT01105611

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Condition: HIV Infections

NCT ID: NCT00038636

The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving Rifampicin

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00411996

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Condition: HIV Infections

NCT ID: NCT00196625

"OK 2004 Study" (Only Kaletra 2004 Study): Study to Evaluate Suspending Nucleosides From Triple-Drug Therapy in HIV Subjects

Condition: HIV Infection

NCT ID: NCT00114933

Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance

Condition: HIV Infections

NCT ID: NCT00046033

Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada

Condition: HIV Infections

NCT ID: NCT00528060

Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01138202

Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIV

Condition: HIV Infections

NCT ID: NCT00000940

Safety and Effectiveness of an Anti-HIV Drug Combination Taken Twice Daily

Condition: HIV Infections

NCT ID: NCT00002241

Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children

Condition: HIV-1 Infection

NCT ID: NCT01139905

Efficacy and Safety of Tenofovir DF/Atazanavir Enhanced With Low Dose of Ritonavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00122577

Steady State PK in Malnourished HIV Infected Children

Condition: HIV Positive; Malnourished

NCT ID: NCT01818258

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Condition: HIV Infections; Pregnancy

NCT ID: NCT00000920

Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir Score

Condition: HIV Infection

NCT ID: NCT00234975

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00849160

Comparison of Treatment Simplification by LPV/r vs Current Treatment Continuation in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00140751

CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes

Condition: Acquired Immunodeficiency Syndrome; HIV Infections

NCT ID: NCT00966160

Disulfiram Interactions With HIV Medications: Clinical Implications

Condition: HIV Infections; Drug Abuse

NCT ID: NCT00878306

Lopinavir/Ritonavir Monotherapy Versus Standard Highly Active Antiretroviral Therapy (HAART) in HIV/HCV Coinfected Patients Starting Treatment With Anti-Hepatitis C Virus (HCV) Therapy

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00437684

Drug Interactions Among Anti-HIV Agents

Condition: HIV Infection

NCT ID: NCT00001766

Once-daily Antiretroviral Therapy in HIV-1 Infected Patients With CD4+ Cell Counts Below 100 Cells/Mcl

Condition: HIV Infections

NCT ID: NCT00532168

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT00855088

Optimizing Antiretroviral Therapy in HIV-Infected Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00207948

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Condition: HIV Infections

NCT ID: NCT00109590

A Study to Evaluate Antiviral Activity of Darunavir + Ritonavir in HIV-1 Infected Adolescents

Condition: HIV-1 Infection

NCT ID: NCT00915655

The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-Infected Pregnant Women.

Condition: HIV Infections

NCT ID: NCT00145561

Efficacy and Safety of Single Versus Double Ritonavir-Boosted Protease Inhibitor (PI)-Based Antiretroviral Therapy (ART) Regimens

Condition: HIV Infection; HIV Infections

NCT ID: NCT00886990

Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)

Condition: HIV Infections

NCT ID: NCT00525733

GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00105079

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00234910

Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected Subjects

Condition: Hypertriglyceridemia; HIV Infection

NCT ID: NCT01010399

Safety and Efficacy of GS-9350-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Condition: HIV-1 Infection

NCT ID: NCT00892437

Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected Adults

Condition: HIV Infections

NCT ID: NCT00179335

Depo-Medroxyprogesterone Acetate (DMPA, Depo-Provera) Use With Certain Anti-HIV Drugs in HIV-Infected Women

Condition: HIV Infections

NCT ID: NCT00016601

Safety and Effectiveness of a New Protease Inhibitor, BMS-232632, in HIV-Positive Patients Who Have Received Previous Treatment

Condition: HIV Infections

NCT ID: NCT00004584

Safety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected Men

Condition: HIV Infections

NCT ID: NCT00063804

Pharmacokinetics and Safety Study of Tipranavir in Combination With Low Dose Ritonavir in Human Immunodeficiency Virus (HIV)-Infected Children

Condition: HIV Infections

NCT ID: NCT00076999

Lopinavir/Ritonavir (Kaletra) PK in Children

Condition: HIV/AIDS Treatment; HIV Infections

NCT ID: NCT00810108

Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV

Condition: HIV Infection; Tuberculosis

NCT ID: NCT01601626

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents

Condition: HIV Infections

NCT ID: NCT00006604

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Condition: HIV Infections

NCT ID: NCT00135395

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00038220

Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV

Condition: HIV Infection

NCT ID: NCT00244712

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00071760

Effect of a Change in HIV Therapy on Liver Steatosis, Inflammation, and Fibrosis

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00023218

An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT01615601

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in Vietnam

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00651066

A Study to Determine the Antiviral Activity of TMC310911 When Administered With Ritonavir in Treatment-Naive Human Immunodeficiency Virus - Type 1 (HIV-1) Infected Patients

Condition: Human Immunodeficiency Virus Type 1

NCT ID: NCT00838162

Interactions Between HIV Protease Inhibitors and Calcium Channel Blockers

Condition: HIV Infections; Cardiovascular Diseases; Hypertension

NCT ID: NCT00039975

Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients

Condition: HIV Infections

NCT ID: NCT00050895

Maternal/Infant Peripartum NVP, Versus Infant Only Peripartum NVP, or Maternal LPV/r in Addition to Standard ZDV Prophylaxis for the Prevention of Perinatal (PMTCT) HIV in Thailand

Condition: HIV Infections; Pregnancy

NCT ID: NCT00409591

ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial Regimens

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00335322

Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00184951

Pharmacodynamics, Safety and Pharmacokinetics of BMS-663068, an HIV Attachment Inhibitor, in HIV-1

Condition: HIV-1 Infections

NCT ID: NCT01009814

Optimisation of Primary HIV1 Infection Treatment(ANRS 147 OPTIPRIM)

Condition: HIV-1 Infections

NCT ID: NCT01033760

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Condition: HIV-1 Infection

NCT ID: NCT01803074

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients

Condition: Chronic Infection With HIV

NCT ID: NCT01829802

Pharmacokinetic Interaction Between the Antimalarial Combination Artemether/Lumefantrine and Combination Antiretroviral Therapy Including Lopinavir/Ritonavir in HIV-infected Adults

Condition: HIV Infections; Malaria

NCT ID: NCT00869700

Induction-Maintenance of Lopinavir/r in HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00159224

Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects

Condition: HIV Infections

NCT ID: NCT01047995

A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT01391013

Study of Lopinavir/ Ritonavir and Lamivudine Versus Standard Therapy in Naïve HIV-1 Infected Subjects.

Condition: HIV Infection

NCT ID: NCT01237444

BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00388492

A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment).

Condition: HIV-1 Infection

NCT ID: NCT00534352

Drug Interaction Study of Famotidine and Atazanavir With Ritonavir in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00384904

A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT00827112

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

Condition: HIV Infections

NCT ID: NCT00607958

A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients

Condition: HIV Infections

NCT ID: NCT00541463

Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women

Condition: HIV Infections

NCT ID: NCT00102986

A Study of Invirase (Saquinavir)/Ritonavir in HIV-Infected Infants and Children.

Condition: HIV Infections

NCT ID: NCT00623597

Drug Interactions of Amprenavir and Efavirenz, in Combination With a Second Protease Inhibitor, in HIV-Negative Volunteers

Condition: HIV Infections

NCT ID: NCT00005762

Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study

Condition: HIV; HIV Infections

NCT ID: NCT01073761

Raltegravir vs. Lopinavir/Ritonavir, Both in Combination With Truvada, in HIV+ Treatment Naive Individuals

Condition: HIV Infections

NCT ID: NCT00632970

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.

Condition: HIV Infections

NCT ID: NCT00435929

A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1

Condition: HIV-1

NCT ID: NCT00823979

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Condition: HIV Infections

NCT ID: NCT00043966

Safety of Saquinavir and High Doses of Lopinavir/Ritonavir in Children With HIV

Condition: HIV Infections

NCT ID: NCT00084058

A Phase 2 Study of the Safety of Ritonavir-Boosted GS-9137 (GS-9137/r) Administered in Combination With Other Antiretroviral Agents for the Treatment of HIV-1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00445146

A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

Condition: HIV Infection

NCT ID: NCT00001688

GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.

Condition: HIV Infections; Infection

NCT ID: NCT00381303

A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years

Condition: HIV Infection

NCT ID: NCT00040664

Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00043953

Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women

Condition: HIV Infections; Pregnancy

NCT ID: NCT00125983

Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.

Condition: HIV Associated Lipodystrophy Syndrome.; HIV; Hypercholesterolemia; Lipoatrophy

NCT ID: NCT00139178

A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT01638650

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Pilot Assessment of Lopinavir/Ritonavir and Maraviroc

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00981318

A Simplified Kaletra® (Lopinavir/Ritonavir)-Based Therapy Versus a Sustiva® (Efavirenz)-Based Standard of Care in Previously Non-Treated HIV-Infected Subjects

Condition: HIV Infections

NCT ID: NCT00075231

TMC114-C202: A Study of Safety, Efficacy, and Tolerability of TMC114 and Low Dose Ritonavir in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00071097

Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression

Condition: Human Immunodeficiency Virus

NCT ID: NCT01599364

Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection

Condition: HIV

NCT ID: NCT01343225

A Comparison of Body Fat Distribution in HIV-1 Infected Patients Receiving, Since the Beginning and for at Least Two Years, an Antiretroviral Therapy Based on Efavirenz or Lopinavir/Ritonavir Combined With Tenofovir + Emtricitabine or Lamivudine

Condition: HIV Infection

NCT ID: NCT01159743

Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy

Condition: HIV Infection; Lipodystrophy; HIV Infections

NCT ID: NCT00865007

Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00640887

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00120393

Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women

Condition: HIV Infections

NCT ID: NCT00044837

KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks

Condition: HIV Infection; Infection, Human Immunodeficiency Virus

NCT ID: NCT00085943

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Condition: HIV Infections

NCT ID: NCT00146328

Switching From PI to RALtegravir in HIV Stable Patients

Condition: HIV Infections

NCT ID: NCT00528892

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Condition: HIV Infections

NCT ID: NCT00513513

Treatment Options for Protease Inhibitor-exposed Children

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT01146873

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Condition: HIV Infections

NCT ID: NCT00144287

Safety and Effectiveness of an Anti-HIV Drug Combination With and Without Hydroxyurea in Patients With Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006339

Study to Evaluate the Influence of Nevirapine to Atazanavir in Steady State Equilibrium in HIV Patients

Condition: HIV Infections

NCT ID: NCT00355719

Antiretroviral Therapy for Advanced HIV Disease in South Africa

Condition: HIV

NCT ID: NCT00342355

Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV

Condition: HIV; Hepatitis B

NCT ID: NCT01125696

Clinical, Virological and Safety Outcomes of a Lopinavir/Ritonavir-Based Regimen in HIV-1 Infected Patients in Routine Clinical Use in China

Condition: HIV-1 Infections

NCT ID: NCT01074931

A Phase I/II Double-Blind Controlled Trial to Determine the Safety and Immunogenicity of HIV-1 MN rgp160 Immuno AG Vaccine Therapy in HIV-Infected Individuals With Greater Than or Equal to 500/mm3 CD4+ T Cells and 200-400/mm3 CD4+ T Cells

Condition: HIV Infections

NCT ID: NCT00000822

Using Drug Levels and Drug Resistance Testing to Select Effective Anti-HIV Drug Combinations in Patients With Drug-resistant HIV

Condition: HIV Infections

NCT ID: NCT00027339

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

Condition: HIV-1 Infections

NCT ID: NCT00830804

Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited Setting

Condition: HIV-1 Infection

NCT ID: NCT01772940

Nevirapine or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir in Human Immunodeficiency Virus (HIV)-1-infected Treatment Naive Adults

Condition: HIV Infections

NCT ID: NCT00389207

Open Label Study of 908/RTV in Combination With Other PIs for the Treatment of Multi PI-Experienced HIV Subjects

Condition: HIV-1

NCT ID: NCT00144833

HIV Antiretroviral Drugs and Metabolism

Condition: HIV Infections

NCT ID: NCT00525239

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Condition: HIV Infection; Hepatitis C

NCT ID: NCT00121017

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Condition: HIV Infections

NCT ID: NCT00012519

A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Condition: HIV Infections

NCT ID: NCT00000914

Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1

Condition: HIV-1

NCT ID: NCT01345630

ABT-378/Ritonavir and Efavirenz in HIV-Infected Patients Who Have Taken More Than One Protease Inhibitor in the Past

Condition: HIV Infections

NCT ID: NCT00004582

Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT00775606

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00006397

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Condition: Human Immunodeficiency Virus - Type 1

NCT ID: NCT00524368

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Safety of and Immune Response to Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in Adults With Acute HIV Infection

Condition: HIV Infections

NCT ID: NCT00084149

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Condition: HIV Infections

NCT ID: NCT00933205

Study of the 48-Week Virologic and Immunologic Response to Lopinavir/Ritonavir (Kaletra) in HIV Positive Adult Patients

Condition: HIV Infections

NCT ID: NCT00116636

Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)

Condition: HIV Infections

NCT ID: NCT00122603

The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00001087

Drug Interaction Study Between Antimalarial and Anti-HIV Medications

Condition: HIV Infections; Malaria

NCT ID: NCT00266058

Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection

Condition: HIV; Hepatitis C; Liver Fibrosis

NCT ID: NCT01231685

Trial About Hepatic Security of Antiretroviral Treatment Based on Kaletra Versus Nevirapine in co-Infected HIV/HCV Patients

Condition: HIV Infections

NCT ID: NCT00661349

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00486330

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00004855

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

Dose Reduction of Lopinavir in Children

Condition: HIV Infections

NCT ID: NCT00887120

Comparison of GW433908/Ritonavir to Nelfinavir When Used With Abacavir and Lamivudine in Patients That Have Not Taken Antiretroviral Drugs

Condition: HIV Infections

NCT ID: NCT00009061

Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment

Condition: HIV

NCT ID: NCT00757783

Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00414518

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Condition: HIV Infections

NCT ID: NCT00017992

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections; Antiretroviral Therapy

NCT ID: NCT00242216

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Condition: HIV Infection

NCT ID: NCT00280969

Characterization of Acute and Recent HIV-1 Infections in Zurich: a Long-Term Observational Study

Condition: HIV Infections

NCT ID: NCT00537966

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens

Condition: HIV Infections

NCT ID: NCT00001091

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Condition: HIV Infections

NCT ID: NCT00245739

A Study of HIV-Disease Development in Aging

Condition: HIV Infections

NCT ID: NCT00006144

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Condition: HIV Infection

NCT ID: NCT01576731

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Condition: HIV Infection

NCT ID: NCT01533272

Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen

Condition: HIV Infections

NCT ID: NCT00014937

Dose Ranging Trial of Tipranavir/Ritonavir in Treatment-Experienced HIV Infected Individuals

Condition: HIV Infections

NCT ID: NCT00034866

Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00619944

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Condition: HIV

NCT ID: NCT01602822

GW873140 In Combination With Kaletra In HIV Infected Subjects

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00102778

Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00707733

Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00096850

Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Ritonavir-Boosted Elvitegravir (EVG/r) Versus Raltegravir (RAL)

Condition: HIV Infection

NCT ID: NCT00708162

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Condition: HIV

NCT ID: NCT01445223

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Condition: HIV Infections

NCT ID: NCT00440271

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy

Condition: HIV-infection

NCT ID: NCT01606722

Induction-Maintenance With Atazanavir in HIV Naïve Patients (The INDUMA Study)

Condition: HIV Infections

NCT ID: NCT00207142

Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice

Condition: HIV Infections

NCT ID: NCT01375881

Double Protease Inhibitor to Darunavir Switch Study

Condition: HIV Infections

NCT ID: NCT00531557

PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)

Condition: HIV Infections

NCT ID: NCT01099579

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Condition: HIV Infections

NCT ID: NCT00552240

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Condition: HIV Infections

NCT ID: NCT00006326

Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIR

Condition: HIV Infections

NCT ID: NCT00043888

PK of Once Daily ART Containing Tenofovir and Atazanavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00273273

The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

Condition: HIV Infections

NCT ID: NCT00540137

Lopinavir Capsules to Kaletra or Invirase Tablets

Condition: HIV Infections

NCT ID: NCT00438152

Depot Contraception With and Without Lopinavir/Ritonavir

Condition: HIV Infection

NCT ID: NCT01231451

Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)

Condition: HIV

NCT ID: NCT01335698

SHARE: Simple HAART With Abacavir, Reyataz, and Epivir

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00426296

RAltegravir Switch STudy: Effects on Endothelial Recovery

Condition: HIV Infection; Endothelial Dysfunction

NCT ID: NCT01453933

Study of Anti-HIV Therapy Intensification

Condition: HIV Infections

NCT ID: NCT00034086

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

Condition: Human Immunodeficiency Virus-1

NCT ID: NCT01384734

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-032)(TERMINATED)

Condition: HIV Infection

NCT ID: NCT00443703

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Condition: Hyperlipidemia; HIV Infections

NCT ID: NCT00160329

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01199731

Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients

Condition: HIV Infections; Lipodystrophy; Wasting Disease

NCT ID: NCT00028314

Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00762892

Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00411957

Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in Africa

Condition: HIV

NCT ID: NCT01088516

Early Access to TMC114/r and Other AVT for Treatment-naive or Early Treatment Experienced in HIV-1 Patients

Condition: HIV-1

NCT ID: NCT01702090

Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients

Condition: HIV-1 Adults Patients; AIDS; Triple Class Failure

NCT ID: NCT01013987

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Condition: HIV Infections

NCT ID: NCT00000941

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Condition: HIV Infections

NCT ID: NCT00224445

Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00262522

Study of Adherence Effects and Clinical Outcomes of Kaletra Based HIV Antiviral Therapy

Condition: HIV Infection

NCT ID: NCT00234962

Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)

Condition: HIV-infected Children

NCT ID: NCT01307124

Efficacy and Safety of VICRIVIROC in HIV-Infected Treatment-Naïve Subjects (Study P04875AM5)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00551018

Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir

Condition: Hepatitis C, Chronic; HIV Infection

NCT ID: NCT01818856

TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options

Condition: HIV Infections

NCT ID: NCT00115050

MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)

Condition: HIV Infection

NCT ID: NCT00443729

Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population

Condition: Human Immunodeficiency Virus

NCT ID: NCT01180075

Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir

Condition: HIV Infections

NCT ID: NCT01031849

Antiretroviral Drug Interaction Study in Volunteers With HIV

Condition: HIV; PCP; Toxoplasmosis

NCT ID: NCT01479361

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

Condition: HIV Infection

NCT ID: NCT00386659

A Post Marketing Surveillance Study Assessing the Long-term Efficacy and Safety of Aptivus Co-administered With Low-dose Ritonavir in Treatment Experienced Patients With HIV-1 Infection in the Daily Clinical Practice.

Condition: HIV Infections

NCT ID: NCT00976950

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Condition: HIV Transmission; HIV Infections

NCT ID: NCT00949234

TMC114IFD3001 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Adults Coming From Any of the Three Ongoing Tibotec-Sponsored Studies With DRV

Condition: HIV-1 Infections

NCT ID: NCT01281813

Universal Use of EFV-TDF-FTC and AZT-3TC-LPV/r Combinations for HIV-1 PMTCT in Pregnant and Breastfeeding Women : a Phase 3 Trial

Condition: HIV Infection; Pregnancy; Breastfeeding; HIV Infections

NCT ID: NCT00936195

Study of Lopinavir/Ritonavir Tablets Comparing Once-Daily Versus Twice-Daily Administration When Coadministered With Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Antiretroviral-Experienced Human Immunodeficiency Virus Type 1 Infected Subjects

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00358917

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

Condition: HIV-1 Infection

NCT ID: NCT01252940

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Condition: HIV Infections

NCT ID: NCT00006152

DRV/r + RPV QD: Efficacy and Toxicity Reduction

Condition: HIV-positive Subjects With HIV-RNA <50 Copies/mL

NCT ID: NCT01792570

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01738555

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

Condition: HIV Infections

NCT ID: NCT00144170

Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection

Condition: HIV

NCT ID: NCT01232127

Abacavir Pharmacokinetic Study in the Absence/Presence of Darunavir/Ritonavir or Raltegravir in HIV-infected Subjects

Condition: HIV

NCT ID: NCT00765271

Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy

Condition: HIV Infections

NCT ID: NCT00357552

Lopinavir (LPV) Dose Reduction

Condition: HIV-1 Infections

NCT ID: NCT01159275

Evaluating the Response to Three Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 28 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission

Condition: HIV Infections

NCT ID: NCT01618305

A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment

Condition: HIV Infections

NCT ID: NCT00000902

A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00296504

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Condition: HIV; Hepatitis C

NCT ID: NCT01225705

Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Impaired And Normal Renal Function

Condition: Human Immunodeficiency Virus (HIV) Infection

NCT ID: NCT00717067

Antiretroviral Regimens Containing Raltegravir for Prophylaxis of Mother-to-child-transmission of HIV Infection

Condition: HIV; Pregnancy

NCT ID: NCT01854762

High Dose Ritonavir/Lopinavir Liquid Formulation in Salvage Therapy for Protease Inhibitor Resistant HIV Disease

Condition: HIV; AIDS

NCT ID: NCT00247143

Pilot Study of Effect of Kaletra on CD4 Response in HIV Positive (+) Patients With Viral Suppression KIMBO Study

Condition: HIV

NCT ID: NCT00344487

MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)

Condition: HIV Infections; HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00122226

A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and Amprenavir

Condition: HIV Infections

NCT ID: NCT00148785

Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected

Condition: HIV-1 Infection; Pf Subclinical Parasitemia

NCT ID: NCT01632891

Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women

Condition: HIV Infections

NCT ID: NCT00621166

Kaletra-isentress Treatment Evaluation

Condition: HIV Infections

NCT ID: NCT00700115

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

Condition: HIV Infections

NCT ID: NCT00118898

ATV/Ritonavir Nevirapine Interaction (USPAC)

Condition: HIV Infections

NCT ID: NCT00162149

A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

Condition: HIV Infections

NCT ID: NCT00312754

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Condition: HIV

NCT ID: NCT01605084

Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects

Condition: HIV Infections

NCT ID: NCT01066962

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00530920

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Condition: HIV Infections

NCT ID: NCT00884793

The Effect of Protease Inhibitors on the Pharmacokinetics of Oral Norethindrone Contraception

Condition: Pregnancy; HIV; AIDS

NCT ID: NCT01667978

Raltegravir Insulin Sensitivity Study

Condition: HIV Infections

NCT ID: NCT00531999

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00427297

Evaluation of Specific Infection-Fighting Cells For Prediction of Immune Response to Anti-HIV and Immune-Boosting Medication

Condition: HIV Infections

NCT ID: NCT00006578

Observational Non-interventional Study (Anwendungsbeobachtung) With Aptivus® (Tipranavir) in HIV-infected Patients.

Condition: HIV Infections

NCT ID: NCT00531206

Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women

Condition: HIV Infected

NCT ID: NCT01394133

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Condition: HIV Infections

NCT ID: NCT00036452

Safety Sudy of Atazanavir Capsules in the Treatment of HIV in Patients Ages 6 - 18 Years

Condition: HIV, Pediatric

NCT ID: NCT01691794

Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy

Condition: HIV

NCT ID: NCT01116817

Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy

Condition: HIV Infections

NCT ID: NCT00099632

Low Dose Atazanavir/r Versus Standard Dose Atazanavir/r (LASA)

Condition: HIV Infections

NCT ID: NCT01159223

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism

Condition: HIV Infections

NCT ID: NCT00135434

HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children

Condition: Malaria; HIV Infections

NCT ID: NCT00978068

Tissue Drug Levels of HIV Medications

Condition: Human Immunodeficiency Virus

NCT ID: NCT01490346

Open-Label Study Comparing Efficacy and Safety of ATV/RTV+3TC With ATV/RTV+TDF/FTC in HIV-Infected, Treatment Naïve Subjects, Followed by Treatment With ATV/RTV+3TC

Condition: HIV

NCT ID: NCT01620944

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00090779

Safety and Efficacy Study of Switching From Epzicom to Truvada

Condition: HIV Infection

NCT ID: NCT00724711

A Study to Compare Two Different Anti-HIV Drug Regimens

Condition: HIV Infections

NCT ID: NCT00000924

Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses.

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00985543

PI Vs. NNRTI Based Therapy for HIV Advanced Disease

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT00162643

Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism

Condition: HIV Infections

NCT ID: NCT00759070

Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome

Condition: HIV-Associated Lipodystrophy Syndrome

NCT ID: NCT00135356

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Condition: HIV Infections

NCT ID: NCT00885664

Intense Acute Infection Study

Condition: Acute HIV Infection

NCT ID: NCT01154673

TMC114-TiDP29-C232 - Study Providing Continued Access to Treatment With Darunavir (DRV)/Ritonavir (Rtv) for Children Coming From Any of the Three Ongoing Tibotec Sponsored Pediatric Studies With DRV

Condition: HIV-1 Infections

NCT ID: NCT01138605

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT00089583

A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01102972

Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00260078

Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir)

Condition: HIV Infections

NCT ID: NCT00571961

Evaluation of 4 New Simplified Antiretroviral Treatments in Naive HIV-1 Infected Patients in Africa (ANRS 12115 DAYANA)

Condition: HIV Infections

NCT ID: NCT00573001

Study of Genetic Polymorphisms in Thai HIV-1 Infected Patients on SQV/r

Condition: HIV Infections

NCT ID: NCT00476502

Dolutegravir Compared to Darunavir/Ritonavir , Each in Combination With Dual Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in ART-naive Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01449929

Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.

Condition: HIV

NCT ID: NCT00460746

Pharmacokinetics of the Tablet Formulation of Lopinavir/r as Standard and Increased Dosage During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00605098

TMC114-TiDP3-C182 - A Study to Compare the Oral Bioavailability of a 800 mg Prototype Tablet Formulation of Darunivar (DRV) to That of the 400 mg Commercial Tablet Formulation in the Presence of Low Dose Ritonavir, Under Fasted and Fed Conditions

Condition: HIV Infections

NCT ID: NCT01052883

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

Switch to Unboosted Atazanavir With Tenofovir Study

Condition: HIV Infection

NCT ID: NCT01351740

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Bone, Immunologic, and Virologic Effects of a Antiretroviral Regimen

Condition: HIV-1 Infection

NCT ID: NCT01400412

TMC114-C214: Trial of TMC114 Administered With Low Dose Ritonavir (RTV) in HIV-1 Infected Treatment Experienced Patients

Condition: HIV Infection

NCT ID: NCT00110877

Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study

Condition: HIV Infections

NCT ID: NCT00885495

Genetic Predictors of Variability in the Drug-drug Interaction Between Darunavir/Ritonavir and Pravastatin

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00630734

Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens

Condition: HIV Infections

NCT ID: NCT00994344

Drug Interaction Study With Atazanavir Administered With and Without Ritonavir and a Cytochrome P450 Substrate Rosiglitazone

Condition: HIV Infections

NCT ID: NCT00362726

Atazanavir and Ritonavir (ATV/RTV) and an Oral Contraceptive in Healthy Females

Condition: HIV Infections

NCT ID: NCT00357604

Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s)

Condition: HIV Infections

NCT ID: NCT00028301

Drug Interaction Study With Famotidine, Atazanavir, and Atazanavir/Ritonavir/Tenofovir

Condition: HIV Infections

NCT ID: NCT00365339

BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes

Condition: HIV Infections

NCT ID: NCT00389402

Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens

Condition: HIV Infections

NCT ID: NCT00627055

Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

Condition: HIV Infections

NCT ID: NCT00344123

Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)

Condition: HIV Infections

NCT ID: NCT00977301

Trial To Assess The Lipid-Lowering Effect Of Adding Tenofovir/Emtricitabine Co-Formulation Vs Placebo To Hiv-1-Infected Subjects With Dyslipidemia And Sustained Viral Load Suppression Under Monotherapy With Ritonavir-Boosted Protease Inhibitors

Condition: HIV; Dyslipidemia

NCT ID: NCT01458977

Atazanavir and Lamivudine for Treatment Simplification

Condition: HIV Infections

NCT ID: NCT00885482

Atazanavir/Ritonavir and Zinc Pharmacokinetic Study

Condition: HIV Infection

NCT ID: NCT01475227

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Condition: HIV Infections

NCT ID: NCT00379405

The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and Saquinavir

Condition: HIV Infections

NCT ID: NCT00000898

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study

Condition: HIV Infections

NCT ID: NCT00192608

A Comparison of Adherence Rates to Ritonavir and Its Accompanying Protease Inhibitor

Condition: HIV Infections

NCT ID: NCT00432783

A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen

Condition: HIV Infections

NCT ID: NCT00135343

Kaletra Sex/Gender Pharmacokinetics (PK) Study: A Switch From Twice Daily to Once Daily Lopinavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT00148759

Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir

Condition: HIV Infections

NCT ID: NCT01294761

Simplification to Atazanavir/Ritonavir + Lamivudine as Maintenance Therapy

Condition: HIV Infection

NCT ID: NCT01307488

Ritonavir-boosted Lopinavir Monotherapy

Condition: HIV

NCT ID: NCT01002898

Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT01049685

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT00711009

Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in Thailand

Condition: HIV Infection

NCT ID: NCT00197639

Atazavanir/Ritonavir-based HAART in Children

Condition: HIV

NCT ID: NCT01656109

Kaletra and Maraviroc in Antiretroviral Therapy (ART)-Naive Patients (KALMAR Study)

Condition: HIV Infections

NCT ID: NCT01068873

Safety and Tolerability Study to Evaluate Lower Dose of GSK2248761 in Antiretroviral Treatment-Naive HIV-1 Infected Adults.

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00945282

Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients

Condition: HIV Infections

NCT ID: NCT00752856

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00608569

Drug Interaction Study Between GSK1349572 and Tipranavir/Ritonavir in Healthy Volunteers

Condition: HIV Infections

NCT ID: NCT01068925

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

Condition: HIV Infections

NCT ID: NCT00756730

Metabolic Effects of Switching Kaletra to Boosted Reyataz

Condition: HIV Infections

NCT ID: NCT00413153

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Condition: HIV; Tuberculosis

NCT ID: NCT01663168

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients

Condition: HIV Infections

NCT ID: NCT00677300

Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations

Condition: HIV Infections; Malaria

NCT ID: NCT00697892

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Condition: HIV Infections

NCT ID: NCT00100646

Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00543101

TMC125-C206: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Condition: HIV

NCT ID: NCT00254046

TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.

Condition: HIV

NCT ID: NCT00255099

Sex, Aging and Antiretroviral Pharmacokinetics

Condition: HIV Infections

NCT ID: NCT00666055

A Study of 1592U89 in Combination With Protease Inhibitors in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00002440

A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment Failure

Condition: HIV Infections

NCT ID: NCT00000918

MARCH Central Nervous System Substudy

Condition: HIV-1 Infection

NCT ID: NCT01637233

Efficacy of Atazanavir/Ritonavir Monotherapy as Maintenance in Patients With Viral Suppression

Condition: HIV-1 Infection

NCT ID: NCT01511809

TMC114-C211: Trial of an Investigational Protease Inhibitor TMC114 With Ritonavir ("TMC114/r") in HIV-1 Infected Patients Who Have Never Been Treated With Antiretroviral Medications.

Condition: HIV

NCT ID: NCT00258557

Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

Condition: HIV Infections

NCT ID: NCT00001119

A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002374

A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00000919

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00002378

HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)

Condition: HIV-Associated Lipodystrophy Syndrome; Cardiovascular Disease

NCT ID: NCT00192660

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Condition: HIV Infections

NCT ID: NCT00000913

Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance

Condition: HIV Infections

NCT ID: NCT00120783

BOOST: Study of Increased Dosage of Lopinavir/Ritonavir (LPV/r)

Condition: HIV Infections

NCT ID: NCT00414284

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Condition: HIV Infection

NCT ID: NCT00352066

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Condition: HIV; HIV Infections

NCT ID: NCT00966329

ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial

Condition: HIV-1

NCT ID: NCT00772902

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

Condition: HIV Infection

NCT ID: NCT00100984

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

Condition: HIV Infections

NCT ID: NCT00002178

Pharmacokinetic Interactions Between DMPA and LPV/Rit Among HIV-Infected Women

Condition: HIV-1 Infection

NCT ID: NCT01296152

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Condition: HIV Infections

NCT ID: NCT00762320

Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315

Condition: HIV Infections

NCT ID: NCT00000891

Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition: HIV Infection

NCT ID: NCT00811954

Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected Patients

Condition: Hepatitis B; Human Immunodeficiency Virus; Hepatitis C, Chronic

NCT ID: NCT00782301

Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00307151

Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study

Condition: HIV Infection; Adverse Drug Reaction; Quality of Life

NCT ID: NCT01679964

A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses

Condition: HIV Infections

NCT ID: NCT00001108

Bioequivalence Study of Generic GPO Saquinavir and Norvir® Versus Invirase® and Norvir®

Condition: HIV Infections

NCT ID: NCT00622141

A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients.

Condition: HIV

NCT ID: NCT01736761

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Condition: HIV Infections

NCT ID: NCT00611039

Pharmacokinetics of Low Dose Ritonavir

Condition: HIV Infections

NCT ID: NCT00622206

Drug Interaction Study With Proton Pump Inhibitor

Condition: HIV Infections

NCT ID: NCT00357240

Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects

Condition: HIV Infections; Protease Inhibitor

NCT ID: NCT00357188

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

A Multicenter Study to Assess the Tolerability of Once Daily Lopinavir/Ritonavir (LPV/r) Liquid Versus Capsules

Condition: HIV Infection

NCT ID: NCT00281606

Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young Adults

Condition: HIV Infections

NCT ID: NCT00977756

Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir

Condition: HIV Infections

NCT ID: NCT01046890

TDM of Generic Lopinavir/Ritonavir 200/50 mg

Condition: HIV

NCT ID: NCT00802334

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Condition: HIV Infections; AIDS-Related Opportunistic Infections

NCT ID: NCT00055120

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

Condition: HIV Infections

NCT ID: NCT01374802

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

Condition: HIV Infections

NCT ID: NCT00054717

Protease Inhibitors to Reduce Malaria Morbidity in HIV-Infected Pregnant Women

Condition: Malaria; HIV Infections

NCT ID: NCT00993031

Atazanavir/Ritonavir Maintenance Therapy

Condition: HIV Infections

NCT ID: NCT00084019

NNRTI/PI Toxicity Switch to Darunavir Study

Condition: HIV

NCT ID: NCT00765154

Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir

Condition: HIV Infection; Fungal Infection

NCT ID: NCT00817765

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

Condition: HIV Infection

NCT ID: NCT01166477

Effects of Anti-HIV Therapy on Treatment for Hepatitis C in HCV/HIV Infected Adults

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00100581

Lopinavir/Ritonavir Monotherapy in Children

Condition: HIV Infections

NCT ID: NCT00626301

A Study of HIV Levels During Pregnancy and After Childbirth

Condition: HIV Infections; Pregnancy

NCT ID: NCT00041964

Open-Label Study to Evaluate Switching From a TDF-Containing Combination Regimen to a TAF-Containing Combination Single Tablet Regimen (STR) in Virologically-Suppressed, HIV-1 Positive Subjects

Condition: HIV; HIV Infections

NCT ID: NCT01815736

Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI

Condition: HIV Infections

NCT ID: NCT00517192

NRTI-Sparing Pilot Study

Condition: HIV; Mitochondrial Toxicity

NCT ID: NCT00143689

The Maraviroc Darunavir/Ritonavir Once Daily Pharmacokinetic Study

Condition: HIV

NCT ID: NCT01348763

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Condition: HIV Infections

NCT ID: NCT00158405

Interaction of Alcohol and Highly Active Antiretroviral Therapy (HAART) in HIV/AIDS and HIV/AIDS With Hepatitis C Virus (HCV) Co-Infection

Condition: HIV Infections; Hepatitis C

NCT ID: NCT00879047

Metabolic Effects of Atazanavir/Ritonavir Versus Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine in naïve HIV-1 Infected Patients

Condition: HIV-1

NCT ID: NCT01274780

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

Condition: HIV Infections

NCT ID: NCT00508222

Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)

Condition: HIV Infections

NCT ID: NCT00491556

Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients

Condition: HIV Infections

NCT ID: NCT00084253

A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy naïve Patients.

Condition: HIV Infections

NCT ID: NCT00144105

Anti-Retrovirals for Kaposi's Sarcoma

Condition: Kaposi's Sarcoma; HIV Infections

NCT ID: NCT00444379

Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)

Condition: Drug Interactions; Human Immunodeficiency Virus

NCT ID: NCT01227590

An Evaluation of the Pharmacological Interaction of Lopinavir/r and Rifampin

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00771498

Strategies for Delivering Anti-HIV Therapy in South Africa

Condition: HIV Infections

NCT ID: NCT00080522

Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth

Condition: HIV Infections

NCT ID: NCT00102960

A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients

Condition: Human Immunodeficiency Virus-Type 1

NCT ID: NCT01726348

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Condition: HIV Infections; Malaria

NCT ID: NCT00719602

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

Condition: HIV Infections

NCT ID: NCT00089505

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

A Prospective Cohort of Children With HIV Infection

Condition: HIV Infections

NCT ID: NCT00476606

Bioequivalence Study of Atazanavir 300 mg Capsule

Condition: HIV Infections

NCT ID: NCT00393328

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

Condition: Cardiovascular Disease; HIV Infections

NCT ID: NCT01066065

A Pilot Study of the Short-Term Effects of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) Compared With Antiretroviral Management Without Plasma GART

Condition: HIV Infections

NCT ID: NCT00000874

Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters

Condition: HIV Infections; Treatment Naive

NCT ID: NCT00851799

Atazanavir/Ritonavir (ATV/RTV) Once a Day (QD) + Raltegravir (RAL) Twice a Day (BID) Stable Switch Study

Condition: HIV, Combination Therapy

NCT ID: NCT01332227

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01383005

Phase IIB Pilot of Atazanavir + Raltegravir

Condition: HIV

NCT ID: NCT00768989

TMC207-TiDP13-C110: Interaction Study With Lopinavir/Ritonavir in Healthy Volunteer

Condition: Tuberculosis; HIV

NCT ID: NCT00828529

Study of Options for Second-Line Effective Combination Therapy (SELECT)

Condition: HIV-1 Infection

NCT ID: NCT01352715

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Special Investigation of Kaletra in Pregnant Women

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076985

Drug Use Investigation of Kaletra

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076972

PENTA Fosamprenavir Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01077635

Evaluation of Kaletra Therapy Over the Long-term

Condition: Human Immunodeficiency Virus

NCT ID: NCT01083810

Drug Interaction Study Between Inhaled Beclomethasone and Protease Inhibitors in Healthy Volunteers

Condition: HIV; Asthma

NCT ID: NCT00936793

Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial

Condition: HIV Infections

NCT ID: NCT00056641

Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz

Condition: Hyperlipidemia; HIV

NCT ID: NCT01695954

Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.

Condition: HIV; Cardiovascular Disease

NCT ID: NCT01258439

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Condition: HIV

NCT ID: NCT01581853

TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.

Condition: HIV

NCT ID: NCT00767117

The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers

Condition: HIV; Fenofibrate; Protease Inhibitors; Hypertriglyceridemia; Glucuronosyltransferase

NCT ID: NCT01148004

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

Condition: HIV; Tuberculosis

NCT ID: NCT00743470

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Kaletra in Combination With Antiretroviral Agents

Condition: Human Immunodeficiency Virus

NCT ID: NCT01076179

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01737359

Roll-Over Protocol To Provide Atv And/Or Truvada For Extended Access

Condition: HIV

NCT ID: NCT01003990

Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens

Condition: Pediatric HIV; HIV Infections

NCT ID: NCT00940771

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00820118

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Condition: HIV Infection

NCT ID: NCT01367210

Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs

Condition: Healthy; HIV Infection

NCT ID: NCT00005673

Genetics and HIV-1 Protease Inhibitors

Condition: HIV

NCT ID: NCT01388543

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections

NCT ID: NCT00001058

3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study

Condition: HIV Infections

NCT ID: NCT00275444

HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir

Condition: Chronic HIV Infection; HCV Coinfection

NCT ID: NCT01222611

Prevention of Lipoatrophy in Patients Treated With Lopinavir/Ritonavir in Monotherapy Versus ZDV + 3TC + ABC

Condition: HIV Infection; HIV Infections

NCT ID: NCT00865475

HIV - Monotherapy in Switzerland (MOST-ch)

Condition: HIV Infections

NCT ID: NCT00531986

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Condition: Acquired Immune Deficiency Syndrome; AIDS; Human Immunodeficiency Virus; HIV Infections

NCT ID: NCT00814879

Pharmacokinetic Study of Super-boosted Lopinavir/Ritonavir Given With Rifampin

Condition: AIDS; Tuberculosis

NCT ID: NCT01700790

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients

Condition: HIV Infections; Lipoatrophy

NCT ID: NCT00978237

Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa

Condition: HIV; Impaired Cognition

NCT ID: NCT01367236

Surveillance of Kaletra in Korean Patients

Condition: HIV-1 Infection

NCT ID: NCT01083173

Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00920088

GSK1349572 Drug Interaction Study With Protease Inhibitors

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00774735

A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00727597

Evaluation of Therapeutic Drug Monitoring of Protease Inhibitors on Virologic Success and Tolerance of Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122590

Tipranavir Expanded Access Program (EAP)

Condition: HIV Infections

NCT ID: NCT00097799

GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir

Condition: Infections, Human Immunodeficiency Virus and Herpesviridae

NCT ID: NCT01209065

TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00896051

Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use

Condition: HIV-1 Patients

NCT ID: NCT01379703

MARCH Renal Substudy

Condition: Proteinuria; HIV

NCT ID: NCT01637259

Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based Regimen

Condition: HIV Infection

NCT ID: NCT00200369

Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children

Condition: HIV

NCT ID: NCT01172535

TMC114-TiDP3-C181: Study to Assess the Pharmacokinetics of Darunavir (DRV) With Different Doses of Ritonavir in Healthy Volunteers.

Condition: HIV; AIDS

NCT ID: NCT00744887

VX-950-TiDP24-C124: A Phase I Trial to Investigate the Potential Pharmacokinetic Interactions Between Telaprevir and Darunavir/Ritonavir and Between Telaprevir and Fosamprenavir/Ritonavir at Steady-state.

Condition: Hepatitis C; Telaprevir; HIV

NCT ID: NCT00775125

Drug Interactions Between Silimarine and Darunavir/Ritonavir

Condition: HIV

NCT ID: NCT01346982

INROADS, Abbreviated Title: Intelence aNd PRezista Once A Day Study

Condition: HIV

NCT ID: NCT01199939

A Study to Assess Cerebrospinal Fluid INflammatory Markers After Addition of Maraviroc to MONotherapy Darunavir/Ritonavir - The CINAMMON Study

Condition: HIV

NCT ID: NCT01680536

Atazanavir Twice Daily

Condition: HIV Infections; Protease Inhibitor

NCT ID: NCT00357721

Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting

Condition: HIV

NCT ID: NCT01236235

Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01637558

Drug Interaction Study Between Atovaquone and Antiretroviral Agents in HIV-1 Infected Patients

Condition: HIV Infections; Malaria

NCT ID: NCT00421473

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

Bone and Body Comp: A Sub Study of the SECOND-LINE Study

Condition: HIV

NCT ID: NCT01513122

Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients

Condition: Human Immunodeficiency Virus

NCT ID: NCT00648999

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Condition: HCV Coinfection; HIV-1 Infection

NCT ID: NCT01335529

Drug Interaction Study

Condition: Antivirals/HIV

NCT ID: NCT00646776

Raltegravir Therapy for Women With HIV and Fat Accumulation

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00656175

Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen

Condition: HIV; Hypercholesterolemia; Dyslipidemia

NCT ID: NCT01705873

Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)

Condition: HIV Infection; Acquired Immunodeficiency Syndrome

NCT ID: NCT01230580

Directly Observed Therapy in High Risk Populations in Newark, NJ

Condition: Directly Observed Therapy; HIV Infections

NCT ID: NCT00285883

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00297076

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Condition: HIV

NCT ID: NCT00931801

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197145

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197197

Effect of the HIV Protease Inhibitors Atazanavir and Lopinavir/Ritonavir on Cardiovascular Disease Risk Factors

Condition: Endothelial Dysfunction

NCT ID: NCT00720590

Study on the Usage, Dosing, Tolerability, and Effectiveness of Kaletra Tablet

Condition: Human Immunodeficiency Virus

NCT ID: NCT01097655

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

Influence of Drug Transporter Expression on the Pharmacokinetics of the HIV Protease Inhibitor Kaletra

Condition: Healthy; Pharmacokinetics

NCT ID: NCT00176033

Long-term Effectiveness and Safety in Hepatitis-co-infected Patients

Condition: Human Immunodeficiency Virus-Infection

NCT ID: NCT01153269

Kaletra: Therapy With Double Protease Inhibitors

Condition: Human Immunodeficiency Virus

NCT ID: NCT01075191

Renal Transplantation and Raltegravir in HIV-Infected Patients

Condition: HIV-1 Infection; Chronic Renal Insufficiency

NCT ID: NCT01453192

Effect of Maraviroc on Endothelial Function in HIV-Infected Patients

Condition: HIV Infection; Cardiovascular Disease; Inflammation; HIV Infections

NCT ID: NCT00844519

An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects

Condition: HIV Infections

NCT ID: NCT00642291

Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00050908

Observational Study Of A Protease Inhibitor (PI) Containing Regimen In Subjects With PI Mutations Selected During Prior Treatment With GW433908 (Fosamprenavir)

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00242840

Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract

Condition: Women's Health; HIV Infection; Genital Diseases, Female

NCT ID: NCT01456962

The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism

Condition: Diabetes; HIV Infections; Insulin Resistance

NCT ID: NCT00259727

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

Condition: HIV Infection

NCT ID: NCT00081588

ALternative TEnofovir Dosing in Adults With Moderate Renal Function Impairment

Condition: HIV

NCT ID: NCT01671982

Pilot Opened Trial in HIV-infected Patients Including an Investigational Marketed Product

Condition: HIV Infections

NCT ID: NCT00773708

GSK706769/KALETRA Drug-drug Interaction Study

Condition: Healthy Subjects; Infection, Human Immunodeficiency Virus

NCT ID: NCT00723775

Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients

Condition: HIV-1 Infection; AIDS

NCT ID: NCT01348308

Pharmacokinetic Interactions With Prednisolone in Healthy Volunteers and HIV-Infected Patients Receiving Single-Dose Prednisone

Condition: Healthy

NCT ID: NCT00072644

Fosamprenavir in Pts With Hepatic Impairment

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01054586

Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents

Condition: ADHD; HIV

NCT ID: NCT01232361

Europe-Africa Research Network for Evaluation of Second-line Therapy

Condition: Human Immunodeficiency Virus; HIV

NCT ID: NCT00988039

TMC114-C213: A Phase II Randomized, Controlled, Partially Blinded Trial to Investigate Dose-response of TMC114/RTV in 3-class-experienced HIV-1 Infected Patients, Followed by an Open-label Period on the Recommended Dose of TMC114/RTV.

Condition: HIV

NCT ID: NCT00650832

The Safety and Effectiveness of 1592U89 Plus 141W94 Plus DMP 266 in Patients With HIV Who Developed a Resistance to Protease Inhibitors

Condition: HIV Infections

NCT ID: NCT00002213

Treatment De-Intensification and Residual HIV-1 in Youth

Condition: HIV-1; HIV Infections

NCT ID: NCT00867854

Study of the Antiviral and Immunological Effects of Intensification of Suppressive Antiretroviral Therapy With Maraviroc

Condition: HIV Infections

NCT ID: NCT00703586

Study of Raltegravir Versus Nucleotide Reverse Transcriptase Inhibitors (NRTIs) as a Backbone in HIV-Infected Subjects Switched From a Stable Boosted Protease Inhibitor (PI) Regimen

Condition: HIV Infections

NCT ID: NCT00717964

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events

Condition: HIV-Infection

NCT ID: NCT01417949

Switch From Tenofovir to Raltegravir for Low Bone Mineral Density

Condition: HIV; Osteopenia; Osteoporosis; HIV Infections

NCT ID: NCT00939874

Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285)(TERMINATED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00243568

Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment

Condition: HIV Infections

NCT ID: NCT00062660

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Condition: HIV Infection; HIV Infections

NCT ID: NCT00943540

Antihyperlipidemic Effects of Oyster Mushrooms

Condition: HIV Infections; Hyperlipidemia

NCT ID: NCT00069524

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022

Condition: HIV-1

NCT ID: NCT01254656

Vicriviroc (SCH 417690) Treatment Protocol in HIV-Infected Subjects: A Rollover Study for ACTG Protocol A5211 (Study P04100AM4)(COMPLETED)

Condition: HIV Infections

NCT ID: NCT00686829

Impact of Raltegravir Intensification on HIV-1-infected Subjects With Complete Viral Suppression Under Monotherapy With Protease Inhibitors

Condition: HIV-1 Infection

NCT ID: NCT01480713

A Study of 141W94 Used Alone or in Combination With Zidovudine Plus 3TC in HIV-Infected Patients

Condition: HIV Infections

NCT ID: NCT00001085

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Condition: HIV Infections

NCT ID: NCT00039741

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Condition: HIV Infections

NCT ID: NCT00052117

Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED)

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00551330

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

Condition: HIV Infections

NCT ID: NCT00042289

Vitamin D Absorption in HIV Infected Young Adults Being Treated With Tenofovir Containing cART

Condition: HIV Infection

NCT ID: NCT01751646

Study of Pharmacokinetics in HIV-infected Women

Condition: HIV Infections

NCT ID: NCT00433979

Safety and Effectiveness of the Selegiline "Patch" for Decreased Mental Function in HIV Patients

Condition: Cognition Disorders; HIV Infections

NCT ID: NCT00013585

Raltegravir and Atazanavir Dosing Strategy Study

Condition: HIV Infection

NCT ID: NCT00874523

Capravirine to Treat Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00006519

Viracept Expanded Access Program

Condition: HIV Infections

NCT ID: NCT00002165

Antimalarial Pharmacology in Children and Pregnant Women in Uganda

Condition: Malaria; HIV

NCT ID: NCT01717885

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Condition: HIV Infections

NCT ID: NCT00294372

Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra

Condition: Children With Confirmed HIV Infection; Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose; Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment

NCT ID: NCT01259219

To Determine if There Are Pharmacokinetic Interactions at Plasma or Intracellular Level Between Nucleosides and Tenofovir

Condition: HIV

NCT ID: NCT00335192

A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista

Condition: Acquired Immune Deficiency Syndrome

NCT ID: NCT01741831

Drug Exposure Registry for GSK2248761, an Investigational NNRTI

Condition: Seizures; Infection, Human Immunodeficiency Virus

NCT ID: NCT01458132

Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)

Condition: Kaposi's Sarcoma

NCT ID: NCT01276236

A PK and Salvage Study for Children With HIV-infection

Condition: HIV Infections

NCT ID: NCT00476359

The Effect of Pregnancy on the Pharmacokinetics of the Kaletra Tablet

Condition: Pregnancy; HIV

NCT ID: NCT00766818

Optimized Antiretroviral Therapy(ART)During Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in HIV-1 Individuals

Condition: HIV Positive Allogeneic Bone Marrow Transplant

NCT ID: NCT01836068

Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1

Condition: Human Immunodeficiency Virus

NCT ID: NCT00781287

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected Antiretroviral Treatment Experienced Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00766597

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

Condition: HIV Infections

NCT ID: NCT00753324

Clinical Trial of CNS-targeted HAART (CIT2)

Condition: HIV Infections

NCT ID: NCT00624195

TMC125-TiDP35-C213: Safety and Antiviral Activity of Etravirine (TMC125) in Treatment-Experienced, HIV Infected Children and Adolescents

Condition: HIV-1

NCT ID: NCT00665847

Early HIV Therapy in Patients With High CD4 Cell Counts

Condition: HIV

NCT ID: NCT01479634

Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study

Condition: HIV Infection; Hyperlipidemia

NCT ID: NCT00225017

Allogeneic Transplant in HIV Patients (BMT CTN 0903)

Condition: Leukemia; Lymphoma; HIV

NCT ID: NCT01410344

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure

Condition: HIV-1 Infection

NCT ID: NCT01641367

Pharmacokinetic and Efficacy of SQV/r 1500/100 Plus Tenofovir/Emtricitabine 300/200 mg

Condition: Saquinavir/Ritonavir BID or Lopinavir/Ritonavir BID

NCT ID: NCT00476983

Co-Administration Of Fosamprenavir With Methadone: A Drug Interaction Study.

Condition: Healthy Subjects

NCT ID: NCT00481182

A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

Condition: AIDS-Related Kaposi's Sarcoma

NCT ID: NCT00834457

Telaprevir Open-Label Study in Co-Infected Patients

Condition: Hepatitis C, Chronic

NCT ID: NCT01500616

Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma

Condition: Sarcoma

NCT ID: NCT00003008

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01290211

Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy Subjects

Condition: Healthy

NCT ID: NCT01140412

Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil

Condition: Healthy Volunteers

NCT ID: NCT00474201

TMC114-TiDP3-C176 - A Study in Healthy Volunteers Investigating the Bioequivalence Between Two Commercially Available 400-mg Tablets to One New 800-mg Tablet of Darunavir (DRV) in the Presence of Low-dose Ritonavir Under Fed and Fasted Conditions

Condition: Healthy

NCT ID: NCT01308658

The Effect of Lopinavir/Ritonavir on Endothelial Function

Condition: Healthy

NCT ID: NCT00076414

BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma

Condition: Kaposi's Sarcoma

NCT ID: NCT00287495